Procept Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Procept Biorobotics Corp
PRCT Stock  USD 57.03  2.00  3.39%   
Procept Biorobotics financial statements provide useful quarterly and yearly information to potential Procept Biorobotics Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Procept Biorobotics financial statements helps investors assess Procept Biorobotics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Procept Biorobotics' valuation are summarized below:
Gross Profit
137.1 M
Profit Margin
(0.41)
Market Capitalization
3.2 B
Enterprise Value Revenue
13.2851
Revenue
224.5 M
There are currently one hundred twenty trending fundamental ratios for Procept Biorobotics Corp that can be evaluated and compared over time across competitors. All traders should check out Procept Biorobotics' recent fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to drop to about 1.4 B in 2025

Procept Biorobotics Total Revenue

235.72 Million

Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 7 M, Interest Income of 11.4 M or Depreciation And Amortization of 4 M, as well as many indicators such as Price To Sales Ratio of 17.76, Dividend Yield of 0.0 or PTB Ratio of 10.96. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.
  
Check out the analysis of Procept Biorobotics Correlation against competitors.

Procept Biorobotics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets325.1 M534 M166 M
Slightly volatile
Short and Long Term Debt Total67.6 M80.2 M40.3 M
Slightly volatile
Other Current Liabilities16.5 M29.6 M7.9 M
Slightly volatile
Total Current Liabilities31.5 M53.1 M16.5 M
Slightly volatile
Other Liabilities171 K180 K864.4 K
Slightly volatile
Property Plant And Equipment Net28.7 M45.6 M16.2 M
Slightly volatile
Current Deferred Revenue10 M9.6 M1.9 M
Slightly volatile
Accounts Payable6.9 M10 M3.6 M
Slightly volatile
Cash230.9 M333.7 M116.8 M
Slightly volatile
Non Current Assets Total33.2 M52.2 M19.7 M
Slightly volatile
Non Currrent Assets Other5.9 M5.6 M1.7 M
Slightly volatile
Other Assets1.091.15722.1 K
Very volatile
Long Term Debt49.8 M51.5 M33.2 M
Slightly volatile
Cash And Short Term Investments230.9 M333.7 M116.8 M
Slightly volatile
Net Receivables87.7 M83.5 M15.7 M
Slightly volatile
Common Stock Shares Outstanding50.2 M52.1 M44.6 M
Slightly volatile
Liabilities And Stockholders Equity325.1 M534 M166 M
Slightly volatile
Non Current Liabilities Total104.1 M78.7 M167.3 M
Slightly volatile
Inventory59 M56.2 M16.9 M
Slightly volatile
Other Current Assets5.3 M8.5 M2.5 M
Slightly volatile
Total Liabilities127 M131.8 M183.3 M
Slightly volatile
Property Plant And Equipment Gross30.8 M53.5 M17.1 M
Slightly volatile
Total Current Assets291.9 M481.8 M146.3 M
Slightly volatile
Net Working Capital260.4 M428.7 M129.8 M
Slightly volatile
Short Term Debt2.8 M1.9 M3.2 M
Very volatile
Intangible Assets1.3 M932 K2 M
Slightly volatile
Property Plant Equipment38.8 M37 M15.3 M
Slightly volatile
Short and Long Term Debt3.6 M4.1 M4.5 M
Slightly volatile
Capital Surpluse422.9 M475.8 M518.8 M
Slightly volatile
Deferred Long Term Liabilities1.2 M1.3 M1.5 M
Slightly volatile
Non Current Liabilities Other381.7 K324 K258.7 K
Slightly volatile

Procept Biorobotics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income11.4 M10.9 M2.6 M
Slightly volatile
Depreciation And Amortization4 M5.2 M3.1 M
Slightly volatile
Interest Expense4.6 M4.2 M2.3 M
Slightly volatile
Selling General Administrative90.1 M171.4 M52.4 M
Slightly volatile
Total Revenue235.7 M224.5 M48.5 M
Slightly volatile
Other Operating Expenses167.9 M321.1 M95.7 M
Slightly volatile
Research Development34.5 M62.3 M21.3 M
Slightly volatile
Cost Of Revenue91.8 M87.4 M24.4 M
Slightly volatile
Total Operating Expenses126.5 M233.7 M74.5 M
Slightly volatile
Reconciled Depreciation3.5 M5.2 M2.2 M
Slightly volatile
Income Tax Expense4.1 M4.2 M2.1 M
Slightly volatile
Non Operating Income Net Other96.8 K108.9 K118.7 K
Slightly volatile

Procept Biorobotics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings1 M1.1 M17.2 M
Slightly volatile
Stock Based Compensation33.4 M31.8 M7.5 M
Slightly volatile
Begin Period Cash Flow174.4 M260.3 M79.8 M
Slightly volatile
Other Cashflows From Financing Activities14.8 M15.6 M43.8 M
Slightly volatile
Depreciation3.6 M5.2 M2.3 M
Slightly volatile
Capital Expenditures7.5 M4.4 M7.3 M
Very volatile
Change To Operating Activities10.6 M10.1 M3.7 M
Slightly volatile
Total Cash From Financing Activities136.9 M180.1 M70.2 M
Slightly volatile
End Period Cash Flow233.1 M336.8 M118.1 M
Slightly volatile
Change To Netincome18.6 M17.7 M4.7 M
Slightly volatile
Sale Purchase Of Stock4.3 M4.5 M134 M
Slightly volatile
Cash And Cash Equivalents Changes163.4 M183.8 M200.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio17.7618.6955205
Slightly volatile
Days Sales Outstanding70.0313673.7822
Slightly volatile
Stock Based Compensation To Revenue0.210.14180.2659
Slightly volatile
Capex To Depreciation0.80.84243.775
Slightly volatile
EV To Sales16.6917.5664202
Slightly volatile
Inventory Turnover1.111.5561.2684
Slightly volatile
Days Of Inventory On Hand293235289
Slightly volatile
Payables Turnover5.278.7125.9393
Pretty Stable
Research And Ddevelopement To Revenue0.260.27751.5782
Slightly volatile
Capex To Revenue0.01870.01960.7902
Slightly volatile
Cash Per Share3.626.40242.4663
Slightly volatile
Days Payables Outstanding48.4841.896162.5649
Pretty Stable
Income Quality0.791.08531.0079
Slightly volatile
Intangibles To Total Assets0.00170.00170.0252
Slightly volatile
Net Debt To EBITDA1.753.09131.197
Slightly volatile
Current Ratio10.929.06868.6089
Slightly volatile
Receivables Turnover5.272.68875.2827
Slightly volatile
Capex Per Share0.120.08460.161
Very volatile
Revenue Per Share4.524.30690.987
Slightly volatile
Interest Debt Per Share1.141.61980.9172
Slightly volatile
Debt To Assets0.290.15030.3267
Slightly volatile
Operating Cycle389370364
Pretty Stable
Days Of Payables Outstanding48.4841.896162.5649
Pretty Stable
Ebt Per Ebit1.130.94620.9986
Slightly volatile
Quick Ratio10.08.01157.6825
Slightly volatile
Net Income Per E B T0.850.971.0169
Pretty Stable
Cash Ratio9.166.28097.1779
Slightly volatile
Cash Conversion Cycle322328300
Very volatile
Days Of Inventory Outstanding293235289
Slightly volatile
Days Of Sales Outstanding70.0313673.7822
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.861.04441.1202
Slightly volatile
Fixed Asset Turnover5.164.91781.7117
Slightly volatile
Debt Ratio0.290.15030.3267
Slightly volatile
Price Sales Ratio17.7618.6955205
Slightly volatile
Asset Turnover0.440.42040.1624
Slightly volatile

Procept Biorobotics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.5 B1.8 B1.8 B
Very volatile
Enterprise Value1.4 B1.6 B1.8 B
Slightly volatile

Procept Fundamental Market Drivers

Cash And Short Term Investments333.7 M

Procept Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Procept Biorobotics Financial Statements

Procept Biorobotics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Procept Biorobotics investors may analyze each financial statement separately, they are all interrelated. The changes in Procept Biorobotics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Procept Biorobotics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue9.6 M10 M
Total Revenue224.5 M235.7 M
Cost Of Revenue87.4 M91.8 M
Stock Based Compensation To Revenue 0.14  0.21 
Research And Ddevelopement To Revenue 0.28  0.26 
Capex To Revenue 0.02  0.02 
Revenue Per Share 4.31  4.52 
Ebit Per Revenue(0.43)(0.45)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Procept Stock Analysis

When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY